PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1447641
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1447641
Hemodynamic Monitoring Devices Market - By Product (Disposables, Monitors), System Type (Invasive, Minimally Invasive, Non-invasive), End-use (Hospitals, Ambulatory Surgical Centers, Homecare Settings) - Global Forecast 2024 - 2032
Global Hemodynamic Monitoring Devices Market size will register a 5.9% CAGR between 2024 and 2032, attributed to the rising demand for continuous monitoring of the hemodynamic status of patients. Healthcare facilities are increasingly recognizing the benefits of real-time monitoring for improving patient outcomes. Coupled with technology advancements, such as wireless connectivity and enhanced accuracy, these devices offer more efficient and user-friendly solutions.
The introduction of new and innovative hemodynamic monitoring devices will further propel the market expansion for catering to the rising need for sophisticated monitoring tools in healthcare settings. For instance, in April 2023, Vygon India introduced Mostcare Up, an advanced hemodynamic monitoring system. This minimally invasive arterial pressure-based monitor utilizes a patented algorithm based on the Pressure Recording Analytical Method (PRAM) for real-time monitoring of subtle hemodynamic variations.
The hemodynamic monitoring devices market is segmented into product, system type, end-use, and region.
With respect to system type, the industry size from the minimally invasive segment will witness 5.9% growth rate through 2032 due to the increasing preference for minimally invasive procedures to offer benefits, such as reduced recovery time and shorter hospital stays. Hemodynamic monitoring devices play a crucial role in these procedures by providing real-time data on a patient's cardiovascular status. Furthermore, technological advancements have resulted in the creation of monitoring devices that are increasingly portable and user-friendly, thereby accelerating their adoption in minimally invasive surgical procedures.
Based on end-use, the hemodynamic monitoring devices market from the ambulatory surgical centers segment will garner 5.8% CAGR up to 2032, driven by the increasing trend towards outpatient surgeries due to their cost-effectiveness and convenience. Ambulatory surgical centers (ASCs) are adopting hemodynamic monitoring devices to ensure patient safety and optimize surgical outcomes. Rising technological advancements have also made these devices more compact and user-friendly for ASC settings.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Base estimates & calculations
- 1.3 Data collection
- 1.4 Forecast parameters
- 1.5 Data sources
- 1.5.1 Primary
- 1.5.2 Secondary
- 1.5.2.1 Paid sources
- 1.5.2.2 Unpaid sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising incidence of chronic diseases across the globe
- 3.2.1.2 Technological advancements in hemodynamic monitoring devices
- 3.2.1.3 Growing adoption of remote hemodynamic monitoring devices
- 3.2.1.4 Growing preference for telehealth services
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 High cost of patient monitoring devices
- 3.2.2.2 Stringent regulatory framework
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Technological landscape
- 3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.4 Competitive positioning matrix
Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Disposables
- 5.3 Monitors
Chapter 6 Market Estimates and Forecast, By System Type, 2018 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Non-invasive
- 6.3 Invasive
- 6.4 Minimally invasive
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals
- 7.3 Ambulatory surgical centers
- 7.4 Homecare settings
- 7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 Becton, Dickinson and Company
- 9.2 Baxter International Inc.
- 9.3 Deltex Medical Group PLC
- 9.4 Edwards Lifesciences Corporation
- 9.5 GE HealthCare
- 9.6 ICU Medical, Inc.
- 9.7 Koninklijke Philips N.V.
- 9.8 Masimo Corporation
- 9.9 Medtronic plc
- 9.10 Nihon Kohden Corporation
- 9.11 OsypkaCardiotek GmbH
- 9.12 Siemens Healthineers AG
- 9.13 Sramek BioDynamics, Inc.
